August 31, 2024First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves자세히 알아보기
July 24, 2024Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix자세히 알아보기
June 05, 2024Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR자세히 알아보기
May 08, 2024Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability자세히 알아보기
April 07, 2024Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It자세히 알아보기
March 11, 2024Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR자세히 알아보기
February 23, 2024Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference자세히 알아보기
February 02, 2024Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve자세히 알아보기
January 02, 2024Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference자세히 알아보기
October 26, 2023CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION자세히 알아보기
October 26, 2023TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION자세히 알아보기
October 24, 2023FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE자세히 알아보기
October 19, 2023EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK자세히 알아보기
May 17, 2023DATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY자세히 알아보기
May 08, 2023EDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA자세히 알아보기
March 06, 2023EDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSIS자세히 알아보기
January 05, 2023EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE자세히 알아보기
November 27, 2022EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT자세히 알아보기
September 17, 2022EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL자세히 알아보기
September 15, 2022EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION자세히 알아보기
August 17, 2022EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK자세히 알아보기
May 23, 2022EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE자세히 알아보기
March 31, 2022EDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIES자세히 알아보기
January 05, 2022EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE자세히 알아보기
December 20, 2021EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENT자세히 알아보기
November 06, 2021Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program자세히 알아보기
November 05, 2021TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to Surgery in Partner 3 Analysis자세히 알아보기
August 02, 2021Edwards Lifesciences initiates $100 million social impact investment fund to advance racial equity자세히 알아보기
July 22, 2021Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR자세히 알아보기
June 01, 2021Edwards Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff자세히 알아보기
May 18, 2021Clinical Data Updates On Edwards' Transcatheter Mitral, Tricuspid Programs Presented At EuroPCR자세히 알아보기
May 18, 2021Real-World Data Confirm Excellent Results For Bicuspid Patients Treated With Edwards SAPIEN 3 TAVR자세히 알아보기
January 31, 2021Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years자세히 알아보기
December 21, 2020Edwards Treats First Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve Disease자세히 알아보기
July 15, 2020Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries자세히 알아보기
July 13, 2020Edwards Lifesciences Agrees To Global Transcatheter Litigation Settlement With Abbott자세히 알아보기
May 18, 2020Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair자세히 알아보기
March 28, 2020Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials In Response To Hospitals' Focus On COVID-19자세히 알아보기
February 24, 2020Edwards Lifesciences To Present At The Cowen 40th Annual Healthcare Conference자세히 알아보기
February 21, 2020Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients자세히 알아보기
January 08, 2020Edwards Lifesciences To Present At The 38th Annual J.P. Morgan Healthcare Conference자세히 알아보기
September 29, 2019Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients자세히 알아보기
June 04, 2019Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference자세히 알아보기
June 03, 2019Edwards Lifesciences Recommends Stockholders Reject "Mini-Tender Offer" By TRC Capital Corporation자세히 알아보기
May 15, 2019Edwards Lifesciences' Every Heartbeat Matters Charitable Initiative On Track to Impact 1.5 Million Underserved People By 2020자세히 알아보기
January 15, 2019Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement자세히 알아보기
December 03, 2018Edwards Receives Clearance For HemoSphere Platform With Intelligent Decision-Support Tools자세히 알아보기
October 08, 2018Edwards Announces Start Of U.S. Study Of Self-Expanding Transcatheter Heart Valve자세히 알아보기
September 26, 2018Edwards Lifesciences' Philanthropy Exceeds Every Heartbeat Matters Goal To Impact One Million Underserved People Ahead Of Schedule자세히 알아보기
August 30, 2018Edwards Lifesciences To Present At The 13th Annual Wells Fargo Healthcare Conference자세히 알아보기
August 02, 2018Edwards Lifesciences To Present at 38th Annual Canaccord Genuity Growth Conference자세히 알아보기
May 24, 2018Edwards Lifesciences To Present At The Bernstein 34th Annual Strategic Decisions Conference자세히 알아보기
May 22, 2018Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve자세히 알아보기
March 23, 2018Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid자세히 알아보기
March 21, 2018Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe자세히 알아보기
March 06, 2018Edwards Lifesciences To Present At The Cowen 38th Annual Health Care Conference자세히 알아보기
January 02, 2018Edwards Lifesciences To Present At The 36th Annual J.P. Morgan Healthcare Conference자세히 알아보기